RhumbLine Advisers’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

RhumbLine Advisers’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-43,684	Closed	-$2.61M	–	3064
2020 Q2	$2.61M	Buy	43,684 +19,095	+78%	+$1.18M	﹤0.01%	1581
2020 Q1	$1.46M	Buy	24,589 +1,743	+8%	+$102K	﹤0.01%	1712
2019 Q4	$1.25M	Buy	22,846 +8,302	+57%	+$310K	﹤0.01%	1981
2019 Q3	$411K	Buy	14,544 +290	+2%	+$10.6K	﹤0.01%	2415
2019 Q2	$473K	Buy	14,254 +7,542	+112%	+$235K	﹤0.01%	2382
2019 Q1	$228K	Buy	+6,712	New	+$213K	﹤0.01%	2692

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

RhumbLine Advisers's PRNB Position: Q3 2020 in Review

RhumbLine Advisers sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 43,684 shares — an estimated $2.61M sold.

RhumbLine Advisers first reported a position in PRNB in Q1 2019 and held it in 6 quarters. The position peaked at $2.61M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

RhumbLine Advisers reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
RhumbLine Advisers sold 43,684 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.61M.
RhumbLine Advisers first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 6 quarters.
RhumbLine Advisers's Principia Biopharma Inc. Common Stock position peaked at $2.61M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.